Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Fast, easy and effective
This article is part of the PlexusDx Education Hub your resource for evidence-based guidance on blood testing & biomarkers
Teva Pharmaceuticals launched the first authorized generic in the United States in June 2024, with Hikma receiving FDA approval for both generic Victoza and generic Saxenda in December 2024
(2001) Oral cobalamin therapy for the treatment of patients with food-cobalamin malabsorption
The 5-amino descriptor indicates an amino substitution at the 5-position of the quinolinium ring, and the resulting compound is part of the quinolinium NNMT inhibitor research lane described in medicinal chemistry literature [4]
US$ 29.66
US$ 25.27
US$ 27.24
US$ 29.42
US$ 26.29
